Download PDF
Z Gastroenterol 2020; 58(07): 645-651
DOI: 10.1055/a-1133-4566
Originalarbeit

Übersicht über die bisher publizierten gastroenterologischen Empfehlungen der „Klug entscheiden“-Initiative

Choosing wisely: Previously published gastroenterological recommendations of the “Klug entscheiden”-initiative
Pia van Leeuwen
  DGVS, Berlin, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

ZusamMenfassung

Dieses Kapitel zeigt eine Übersicht über alle im Rahmen der Initiative „Klug entscheiden“ bisher publizierten gastroenterologischen Klug entscheiden-Empfehlungen.

Abstract

This chapter is a summary of gastroenterological recommendations published as part of the “Klug entscheiden”-initiative.

Schlüsselwörter

Klug entscheiden - Gastroenterologie - Stoffwechselkrankheiten - Verdauungskrankheiten

Key words

Choosing wisely - gastroenterology - metabolic diseases - digestive diseases


Publication History

Received: 26 February 2020

Accepted: 05 March 2020

Article published online:
13 July 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Preiß JC, Bokemeyer B, Buhr HJ. et al. Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014. Z Gastroenterol 2014; 52: 1431-1484
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Mahid SS, Minor KS, Soto RE. et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006; 81: 1462-1471
    CrossrefPubMedGoogle Scholar
  • 3 Timmer A, Sutherland LR. et al. Oral contraceptive use and smoking are risk factors for relapse in Crohn’s disease. Gastroenterology 1998; 114: 1143-1150
    CrossrefPubMedGoogle Scholar
  • 4 Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. J Clin Gastroenterol 2005; 39: 32-35
    PubMedGoogle Scholar
  • 5 Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn’s disease. Aliment Pharmacol Ther 2005; 21: 921-931
    CrossrefPubMedGoogle Scholar
  • 6 Cosnes J, Carbonnel F, Beaugerie L. et al. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 1996; 110: 424-431
    CrossrefPubMedGoogle Scholar
  • 7 Andreas S, Batra A, Behr J. et al. Tabakentwöhnung bei COPD. Pneumologie 2014; 68: 237-258
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Dignass A, Preiß JC, Aust DE. et al. Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 – Ergebnisse einer Evidenzbasierten Konsensuskonferenz. Z Gastroenterol 2011; 49: 1276-1341
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Steinhart AH, Ewe K, Griffiths AM. et al Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 2003: Cd000301
    PubMedGoogle Scholar
  • 10 Lindgren S, Lofberg R, Bergholm L. et al. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Scand J Gastroenterol 2002; 37: 705-710
    PubMedGoogle Scholar
  • 11 Meyers S, Lerer PK, Feuer EJ. et al. Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol 1987; 9: 50-54
    CrossrefPubMedGoogle Scholar
  • 12 Lichtenstein GR, Feagan BG, Cohen RD. et al. Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol 2012; 107: 1409-1422
    CrossrefPubMedGoogle Scholar
  • 13 Greten TF, Malek NP, Schmidt S. et al. Diagnostik und Therapie des hepatozellulären Karzinoms. Z Gastroenterol 2013; 51: 1269-1326
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022
    CrossrefPubMedGoogle Scholar
  • 15 Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417-422
    PubMedGoogle Scholar
  • 16 Chen JG, Parkin DM, Chen QG. et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 2003; 10: 204-209
    CrossrefPubMedGoogle Scholar
  • 17 Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med 2014; 11: e1001624
    CrossrefPubMedGoogle Scholar
  • 18 (AASLD) AAftSoLD. Five Things Physicians and Patients Should Question. 2015
    PubMedGoogle Scholar
  • 19 Marrero JA, Ahn J, Rajender Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 2014; 109: 1328-1347 ; quiz 1348
    CrossrefPubMedGoogle Scholar
  • 20 Claudon M, Dietrich CF, Choi BI. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Med 2013; 34: 11-29
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Shaked O, Siegelman ES, Olthoff K. et al. Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol 2011; 9: 547-562.e1–4
    CrossrefPubMedGoogle Scholar
  • 22 Ehrl D, Rothaug K, Herzog P. et al. Incidentaloma of the Liver: Management of a Diagnostic and Therapeutic Dilemma. HPB Surgery 2012; 2012: 14
    PubMedGoogle Scholar
  • 23 Kuo YH, Wang JH, Lu SN. et al. Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography. J Clin Ultrasound 2009; 37: 132-137
    CrossrefPubMedGoogle Scholar
  • 24 Lammert F, Neubrand MW, Bittner R. et al. S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten und der Deutschen Gesellschaft für Viszeralchirurgie zur Diagnostik und Behandlung von Gallensteinen. Z Gastroenterol 2007; 45: 971-1001
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Friedman GD, Raviola CA, Fireman B. Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 1989; 42: 127-136
    CrossrefPubMedGoogle Scholar
  • 26 Attili AF, De Santis A, Capri R. et al. The natural history of gallstones: the GREPCO experience. The GREPCO Group. Hepatology 1995; 21: 655-660
    PubMedGoogle Scholar
  • 27 McSherry CK, Ferstenberg H, Calhoun WF. et al. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg 1985; 202: 59-63
    PubMedGoogle Scholar
  • 28 Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982; 307: 798-800
    CrossrefPubMedGoogle Scholar
  • 29 Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol 2000; 95: 1402-1410
    CrossrefPubMedGoogle Scholar
  • 30 Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg 1993; 165: 399-404
    CrossrefPubMedGoogle Scholar
  • 31 UK guidelines for the management of acute pancreatitis. Gut 2005; 54 (Suppl. 03) iii1-iii9
    PubMedGoogle Scholar
  • 32 Tenner S, Baillie J, DeWitt J. et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013; 108: 1400-1415; 1416
    CrossrefPubMedGoogle Scholar
  • 33 Working Group IAP/APA Acute Pancreatitis Guidelines: IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13: e1-e15
    CrossrefPubMedGoogle Scholar
  • 34 Bollen TL, Singh VK, Maurer R. et al. A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol 2012; 107: 612-619
    CrossrefPubMedGoogle Scholar
  • 35 Fleszler F, Friedenberg F, Krevsky B. et al. Abdominal computed tomography prolongs length of stay and is frequently unnecessary in the evaluation of acute pancreatitis. Am J Med Sci 2003; 325: 251-255
    CrossrefPubMedGoogle Scholar
  • 36 Spanier BW, Nio Y, van der Hulst RW. et al. Practice and yield of early CT scan in acute pancreatitis: a Dutch Observational Multicenter Study. Pancreatology 2010; 10: 222-228
    CrossrefPubMedGoogle Scholar
  • 37 Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet 2015; 386: 85-96
    CrossrefPubMedGoogle Scholar
  • 38 London NJ, Leese T, Lavelle JM. et al. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: a prospective study. Br J Surg 1991; 78: 1452-1456
    CrossrefPubMedGoogle Scholar
  • 39 Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002; 223: 603-613
    CrossrefPubMedGoogle Scholar
  • 40 Banks PA, Bollen TL, Dervenis C. et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111
    CrossrefPubMedGoogle Scholar
  • 41 Tsuji Y, Yamamoto H, Yazumi S. et al. Perfusion computerized tomography can predict pancreatic necrosis in early stages of severe acute pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 1484-1492
    CrossrefPubMedGoogle Scholar
  • 42 Seufferlein T, Porzner M, Becker T. et al. S3-Leitlinie zum exokrinen Pankreaskarzinom. Z Gastroenterol 2013; 51: 1395-1440
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Oettle H, Post S, Neuhaus P. et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. Jama 2007; 297: 267-277
    CrossrefPubMedGoogle Scholar
  • 44 Ueno H, Kosuge T, Matsuyama Y. et al. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009; 101: 908-915
    CrossrefPubMedGoogle Scholar
  • 45 Stocken DD, Buchler MW, Dervenis C. et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005; 92: 1372-1381
    CrossrefPubMedGoogle Scholar
  • 46 Neoptolemos JP, Stocken DD, Bassi C. et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. Jama 2010; 304: 1073-1081
    CrossrefPubMedGoogle Scholar
  • 47 Yoshitomi H, Togawa A, Kimura F. et al. A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer. Cancer 2008; 113: 2448-2456
    CrossrefPubMedGoogle Scholar
  • 48 Pox C, Aretz S, Bischoff SC. et al. S3-Leitlinie Kolorektales Karzinom Version 1.0 – Juni 2013 AWMF-Registernummer: 021/007OL. Z Gastroenterol 2013; 51: 753-854
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. Gastrointest Endosc 2001; 53: 620-627
    CrossrefPubMedGoogle Scholar
  • 50 Brenner H, Chang-Claude J, Seiler CM. et al. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 2011; 29: 3761-3767
    CrossrefPubMedGoogle Scholar
  • 51 Rex DK, Cummings OW, Helper DJ. et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment]. Gastroenterology 1996; 111: 1178-1181
    CrossrefPubMedGoogle Scholar
  • 52 Singh H, Nugent Z, Mahmud SM. et al Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 2010; 105: 663-673 ; quiz 674
    CrossrefPubMedGoogle Scholar
  • 53 Bertagnolli MM, Eagle CJ, Zauber AG. et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006; 355: 873-884
    CrossrefPubMedGoogle Scholar
  • 54 Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007; 146: 361-364
    PubMedGoogle Scholar
  • 55 Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603-1613
    CrossrefPubMedGoogle Scholar
  • 56 Chan AT, Giovannucci EL, Meyerhardt JA. et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. Jama 2005; 294: 914-923
    CrossrefPubMedGoogle Scholar
  • 57 Riphaus A, Wehrmann T, Hausmann J. et al. Update S3-Leitlinie „Sedierung in der gastrointestinalen Endoskopie“ 2014 (AWMF-Register-Nr. 021/014). Z Gastroenterol 2015; 53: E1-E1
    Article in Thieme ConnectPubMedGoogle Scholar
  • 58 Dumonceau JM, Riphaus A, Aparicio JR. et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anaesthesiologist administration of propofol for GI endoscopy. Eur J Anaesthesiol 2010; 27: 1016-1030
    CrossrefPubMedGoogle Scholar
  • 59 Dumonceau JM, Riphaus A, Aparicio JR. et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy 2010; 42: 960-974
    Article in Thieme ConnectPubMedGoogle Scholar
  • 60 Jain R, Ikenberry SO, Anderson MA. et al. Minimum staffing requirements for the performance of GI endoscopy. Gastrointest Endosc 2010; 72: 469-470
    CrossrefPubMedGoogle Scholar
  • 61 Vargo JJ, Cohen LB, Rex DK. et al. Position statement: Nonanesthesiologist administration of propofol for GI endoscopy. Gastroenterology 2009; 137: 2161-2167
    CrossrefPubMedGoogle Scholar
  • 62 Holster IL, Kuipers EJ. Management of acute nonvariceal upper gastrointestinal bleeding: current policies and future perspectives. World J Gastroenterol 2012; 18: 1202-1207
    CrossrefPubMedGoogle Scholar
  • 63 Sbrozzi-Vanni A, Zullo A, Di Giulio E. et al. Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey. Dig Liver Dis 2010; 42: 773-776
    CrossrefPubMedGoogle Scholar
  • 64 Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101: 848-863
    CrossrefPubMedGoogle Scholar
  • 65 Sanchez-Delgado J, Gene E, Suarez D. et al. Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol 2011; 106: 398-405
    PubMedGoogle Scholar
  • 66 Götz M. Deutsche Gesellschaft für G, Verdauungs- und S, et al. S2k-Leitlinie Gastrointestinale Blutung. Z Gastroenterol 2017; 55: 883-936
    Article in Thieme ConnectPubMedGoogle Scholar
  • 67 Nidegger D, Ragot S, Berthelemy P. et al. Cirrhosis and bleeding: the need for very early management. J Hepatol 2003; 39: 509-514
    CrossrefPubMedGoogle Scholar
  • 68 Denzer U, Beilenhoff U, Eickhoff A. et al. S2k-Leitlinie Qualitätsanforderungen in der gastrointestinalen Endoskopie, AWMF Register Nr. 021–022. Z Gastroenterol 2015; 53: E1-E227
    Article in Thieme ConnectPubMedGoogle Scholar
  • 69 Tripathi D, Stanley AJ, Hayes PC. et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2015; 64: 1680-1704
    CrossrefPubMedGoogle Scholar
  • 70 D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354
    PubMedGoogle Scholar
  • 71 Wells M, Chande N, Adams P. et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther 2012; 35: 1267-1278
    CrossrefPubMedGoogle Scholar
  • 72 Banares R, Albillos A, Rincon D. et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35: 609-615
    CrossrefPubMedGoogle Scholar
  • 73 Villanueva C, Ortiz J, Sabat M. et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 1999; 30: 384-389
    CrossrefPubMedGoogle Scholar
  • 74 Sung JJ, Chung SC, Yung MY. et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346: 1666-1669
    CrossrefPubMedGoogle Scholar
  • 75 Besson I, Ingrand P, Person B. et al. Sclerotherapy with or without Octreotide for Acute Variceal Bleeding. New England Journal of Medicine 1995; 333: 555-560
    CrossrefPubMedGoogle Scholar
  • 76 de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743-752
    CrossrefPubMedGoogle Scholar
  • 77 Augustin S, Gonzalez A, Genesca J. Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol 2010; 2: 261-274
    CrossrefPubMedGoogle Scholar
  • 78 Seo YS, Park SY, Kim MY. et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology 2014; 60: 954-963
    CrossrefPubMedGoogle Scholar
  • 79 MacKersie AB, Lane MJ, Gerhardt RT. et al. Nontraumatic acute abdominal pain: unenhanced helical CT compared with three-view acute abdominal series. Radiology 2005; 237: 114-122
    CrossrefPubMedGoogle Scholar
  • 80 Stapakis JC, Thickman D. Diagnosis of pneumoperitoneum: abdominal CT vs. upright chest film. J Comput Assist Tomogr 1992; 16: 713-716
    CrossrefPubMedGoogle Scholar
  • 81 Haller O, Karlsson L, Nyman R. Can low-dose abdominal CT replace abdominal plain film in evaluation of acute abdominal pain?. Ups J Med Sci 2010; 115: 113-120
    CrossrefPubMedGoogle Scholar
  • 82 Hainaux B, Agneessens E, Bertinotti R. et al. Accuracy of MDCT in predicting site of gastrointestinal tract perforation. Am J Roentgenol 2006; 187: 1179-1183
    CrossrefPubMedGoogle Scholar
  • 83 Borofsky S, Taffel M, Khati N. et al. The emergency room diagnosis of gastrointestinal tract perforation: the role of CT. Emerg Radiol 2015; 22: 315-327
    CrossrefPubMedGoogle Scholar
  • 84 Saturnino PP, Pinto A, Liguori C. et al. Role of Multidetector Computed Tomography in the Diagnosis of Colorectal Perforations. Semin Ultrasound CT MR 2016; 37: 49-53
    CrossrefPubMedGoogle Scholar
  • 85 Ng CS, Watson CJ, Palmer CR. et al. Evaluation of early abdominopelvic computed tomography in patients with acute abdominal pain of unknown cause: prospective randomised study. Bmj 2002; 325: 1387
    CrossrefPubMedGoogle Scholar
  • 86 Kowalczyk L, Forsmark CE, Ben-David K. et al. Algorithm for the management of endoscopic perforations: a quality improvement project. Am J Gastroenterol 2011; 106: 1022-1027
    CrossrefPubMedGoogle Scholar
  • 87 Paspatis GA, Dumonceau JM, Barthet M. et al. Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2014; 46: 693-711
    Article in Thieme ConnectPubMedGoogle Scholar
  • 88 Barkun AN, Bardou M, Kuipers EJ. et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152: 101-113
    PubMedGoogle Scholar
  • 89 Adler DG, Leighton JA, Davila RE. et al. ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004; 60: 497-504
    CrossrefPubMedGoogle Scholar
  • 90 Gralnek IM, Dumonceau JM, Kuipers EJ. et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: a1-a46
    Article in Thieme ConnectPubMedGoogle Scholar
  • 91 Chiu PW, Joeng HK, Choi CL. et al. High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial. Endoscopy 2016; 48: 717-722
    Article in Thieme ConnectPubMedGoogle Scholar
  • 92 El Ouali S, Barkun AN, Wyse J. et al. Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc 2012; 76: 283-292
    CrossrefPubMedGoogle Scholar
  • 93 Imperiale TF, Kong N. Second-look endoscopy for bleeding peptic ulcer disease: a decision-effectiveness and cost-effectiveness analysis. J Clin Gastroenterol 2012; 46: e71-e75
    CrossrefPubMedGoogle Scholar
  • 94 Qureshi W, Adler DG, Davila R. et al. ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc 2005; 62: 651-655
    CrossrefPubMedGoogle Scholar
  • 95 Theilacker C, Ludewig K, Serr A. et al. Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study. Clin Infect Dis 2016; 62: 871-878
    CrossrefPubMedGoogle Scholar
  • 96 RKI. Wissenschaftliche Begründung für die Aktualisierung der Empfehlungen zur Indikationsimpfung gegen Pneumokokken für Risikogruppen. EpiBull 2016; 37: 385-406
    PubMedGoogle Scholar
  • 97 Ljungman P, Cordonnier C, Einsele H. et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44: 521-526
    CrossrefPubMedGoogle Scholar
  • 98 Onkologie AIidHu. Empfehlung der AGIHO zur Pneumokokkenimpfung bei hämatologischen und onkologischen Patienten im Erwachsenenalter. 2019
    PubMedGoogle Scholar
  • 99 French N, Gordon SB, Mwalukomo T. et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010; 362: 812-822
    CrossrefPubMedGoogle Scholar
  • 100 French N, Nakiyingi J, Carpenter LM. et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355: 2106-2111
    CrossrefPubMedGoogle Scholar